The global hemostasis analyzers market was valued at USD 4.36 Billion in 2022 and is projected to reach USD 9.47 Billion by 2032, exhibiting a significant compound annual growth rate (CAGR) of 9% throughout the forecast period. Key drivers of market revenue growth include the increasing prevalence of bleeding disorders and the growing number of surgeries and trauma cases, as well as the...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά